Scott P. Webster

2.7k total citations
65 papers, 1.9k citations indexed

About

Scott P. Webster is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Behavioral Neuroscience. According to data from OpenAlex, Scott P. Webster has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 15 papers in Behavioral Neuroscience. Recurrent topics in Scott P. Webster's work include Hormonal Regulation and Hypertension (31 papers), Stress Responses and Cortisol (15 papers) and Tryptophan and brain disorders (10 papers). Scott P. Webster is often cited by papers focused on Hormonal Regulation and Hypertension (31 papers), Stress Responses and Cortisol (15 papers) and Tryptophan and brain disorders (10 papers). Scott P. Webster collaborates with scholars based in United Kingdom, United States and Mexico. Scott P. Webster's co-authors include Brian R. Walker, Margaret Binnie, Dominic J. Campopiano, Robert L. Baxter, Jonathan R. Seckl, Samuel Estrada‐Soto, Gabriel Navarrete‐Vázquez, Rolffy Ortíz‐Andrade, Lindsay Sawyer and Dmitry Alexeev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Scott P. Webster

63 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott P. Webster United Kingdom 26 706 603 282 262 223 65 1.9k
Mohammad Soukhtanloo Iran 32 785 1.1× 254 0.4× 86 0.3× 151 0.6× 263 1.2× 159 2.7k
Karen Wagner United States 32 598 0.8× 531 0.9× 377 1.3× 43 0.2× 432 1.9× 99 2.9k
Yoshiji Ohta Japan 27 739 1.0× 202 0.3× 86 0.3× 112 0.4× 159 0.7× 114 2.5k
Yossi Gilgun‐Sherki Israel 20 949 1.3× 139 0.2× 183 0.6× 46 0.2× 301 1.3× 39 2.8k
Jayesh Mudgal India 26 573 0.8× 151 0.3× 152 0.5× 63 0.2× 246 1.1× 92 1.9k
Elżbieta Wyska Poland 26 671 1.0× 76 0.1× 130 0.5× 105 0.4× 468 2.1× 111 2.0k
M. Begoña Ruiz‐Larrea Spain 22 506 0.7× 308 0.5× 162 0.6× 32 0.1× 116 0.5× 53 2.0k
Reinhard Berkels Germany 25 523 0.7× 129 0.2× 126 0.4× 64 0.2× 296 1.3× 46 2.2k
Bernd Moosmann Germany 23 1.1k 1.5× 167 0.3× 311 1.1× 43 0.2× 113 0.5× 46 2.1k
Jianhui Rong Hong Kong 28 989 1.4× 67 0.1× 135 0.5× 59 0.2× 229 1.0× 82 2.2k

Countries citing papers authored by Scott P. Webster

Since Specialization
Citations

This map shows the geographic impact of Scott P. Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott P. Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott P. Webster more than expected).

Fields of papers citing papers by Scott P. Webster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott P. Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott P. Webster. The network helps show where Scott P. Webster may publish in the future.

Co-authorship network of co-authors of Scott P. Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Scott P. Webster. A scholar is included among the top collaborators of Scott P. Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott P. Webster. Scott P. Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, John, Luchuo Engelbert Bain, Angus J. Morrison, et al.. (2025). Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments. Journal of Medicinal Chemistry. 68(6). 6815–6831. 1 indexed citations
2.
Brown, Simon, A. Malinowska, Laura Clark, et al.. (2025). Small Interfering RNA Therapy Targeting the Long Noncoding RNA SMILR for Therapeutic Intervention in Coronary Artery Bypass Graft Failure. JACC Basic to Translational Science. 10(11). 101364–101364.
3.
Brossaud, Julie, Clémentine Bosch‐Bouju, Nathalie Marissal‐Arvy, et al.. (2023). Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11β-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency. Diabetologia. 66(9). 1735–1747. 2 indexed citations
4.
Khan, Shazia, Dawn E. W. Livingstone, Agnieszka Zielińska, et al.. (2023). Contribution of local regeneration of glucocorticoids to tissue steroid pools. Journal of Endocrinology. 258(3). 1 indexed citations
5.
Livingstone, Dawn E. W., Karen Sooy, Catherine Sykes, et al.. (2023). 5α‐Tetrahydrocorticosterone: A topical anti‐inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis. British Journal of Pharmacology. 181(8). 1256–1267. 3 indexed citations
6.
Zheng, Xiaozhong, Lucile Neyton, Iain Uings, et al.. (2023). Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis. Cell Reports. 42(8). 112763–112763. 9 indexed citations
7.
Muir, Morwenna, John C. Dawson, Martin Lee, et al.. (2023). 11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis. PLoS ONE. 18(3). e0255709–e0255709. 1 indexed citations
8.
Hendrick, Richard J., et al.. (2020). A Novel Robotic Endoscopic Device Used for Operative Hysteroscopy. Journal of Minimally Invasive Gynecology. 27(7). 1631–1635. 6 indexed citations
9.
Zheng, Xiaozhong, Ailiang Zhang, Margaret Binnie, et al.. (2019). Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury. Experimental & Molecular Medicine. 51(2). 1–14. 43 indexed citations
10.
Kitamura, Akihiro, Yasmina Manso, Jessica Duncombe, et al.. (2017). Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion. Scientific Reports. 7(1). 4299–4299. 37 indexed citations
11.
Hutchinson, Jonathan P., Paul Rowland, Carl Haslam, et al.. (2017). Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nature Communications. 8(1). 15827–15827. 37 indexed citations
12.
Webster, Scott P., John P. Iredale, Xiaozhong Zheng, et al.. (2017). Detecting drug-target binding in cells using fluorescence-activated cell sorting coupled with mass spectrometry analysis. Methods and Applications in Fluorescence. 6(1). 15002–15002. 6 indexed citations
13.
McBride, Andrew, Margaret Binnie, F. Javier Luque, et al.. (2015). Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry. 23(24). 7607–7617. 4 indexed citations
14.
Mole, Damian J., et al.. (2014). A Magnetic Bead–Based Ligand Binding Assay to Facilitate Human Kynurenine 3-Monooxygenase Drug Discovery. SLAS DISCOVERY. 20(2). 292–298. 8 indexed citations
15.
Liu, Xiaoxia, Sophie Turban, Roderick N. Carter, et al.. (2014). β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell Destruction. Frontiers in Endocrinology. 5. 165–165. 8 indexed citations
16.
Turban, Sophie, Xiaoxia Liu, Lynne Ramage, et al.. (2012). Optimal Elevation of β-Cell 11β-Hydroxysteroid Dehydrogenase Type 1 Is a Compensatory Mechanism That Prevents High-Fat Diet–Induced β-Cell Failure. Diabetes. 61(3). 642–652. 23 indexed citations
17.
Webster, Scott P., Margaret Binnie, Karen Sooy, et al.. (2010). Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles. Bioorganic & Medicinal Chemistry Letters. 20(11). 3265–3271. 22 indexed citations
18.
Torres‐Piedra, Mariana, Rolffy Ortíz‐Andrade, Rafael Villalobos‐Molina, et al.. (2010). A comparative study of flavonoid analogues on streptozotocin–nicotinamide induced diabetic rats: Quercetin as a potential antidiabetic agent acting via 11β-Hydroxysteroid dehydrogenase type 1 inhibition. European Journal of Medicinal Chemistry. 45(6). 2606–2612. 110 indexed citations
19.
Breen, Rachel, et al.. (2003). The mechanism of 7,8-diaminopelargonate synthase; the role of S-adenosylmethionine as the amino donor. Organic & Biomolecular Chemistry. 1(20). 3498–3498. 15 indexed citations
20.
Alexeev, Dmitry, Marina Alexeeva, Robert L. Baxter, et al.. (1998). The crystal structure of 8-amino-7-oxononanoate synthase: a bacterial PLP-dependent, acyl-CoA-condensing enzyme 1 1Edited by R. Huber. Journal of Molecular Biology. 284(2). 401–419. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026